• Here you can see the latest Cisplatin Cyclophosphamide Lomustine Vincristine Sulfate Radiation Therapy Brain articles that have been published worldwide. (bioportfolio.com)
  • We have published hundreds of Cisplatin Cyclophosphamide Lomustine Vincristine Sulfate Radiation Therapy Brain news stories on BioPortfolio along with dozens of Cisplatin Cyclophosphamide Lomustine Vincristine Sulfate Radiation Therapy Brain Clinical Trials and PubMed Articles about Cisplatin Cyclophosphamide Lomustine Vincristine Sulfate Radiation Therapy Brain for you to read. (bioportfolio.com)
  • In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cisplatin Cyclophosphamide Lomustine Vincristine Sulfate Radiation Therapy Brain Companies in our database. (bioportfolio.com)
  • We investigated the toxicity and efficacy of lomustine plus bevacizumab (lom-bev) in a community-based patient cohort and made a comparison to another frequently used combination therapy consisting of irinotecan plus bevacizumab (iri-bev). (bioportfolio.com)
  • Lomustine is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body. (wellspan.org)
  • Additionally, L:G ratio of PLGA 75:25, lower volume of organic solvent (1:10 organic phase: aqueous phase), higher initial drug content (10mg) enhanced the drug entrapment efficiency and maintained lomustine concentration in blood for an extended time period, elevated lomustine concentration in lungs and slowed the elimination of lomustine. (omicsonline.org)
  • No information is available regarding liver toxicity in cats on lomustine so currently the canine monitoring protocols are recommended for both species. (marvistavet.com)
  • The systematic investigation reported here promises the development of PLGA nanoparticles loaded with lomustine when tested in Lung Cancer cell line L132 and toxicological/ histopathological studies in albino mice. (omicsonline.org)
  • There is a slight risk of developing a blood cancer such as leukemia years after taking lomustine. (chemocare.com)
  • Using lomustine may increase your risk of developing other types of cancer, such as leukemia. (wellspan.org)
  • The amount of lomustine that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. (chemocare.com)
  • Because lomustine targets rapidly dividing cells, the cells of the bone marrow are vulnerable whether or not there is cancer present. (marvistavet.com)
  • On the day your pet receives lomustine and for several days following, gloves should be worn while removing all body wastes from the pet from the environment. (marvistavet.com)